• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Basilea Pharmaceutica

+ Add to Watchlist

BSLN:SW

102.00 CHF 1.00 0.97%

As of 11:43:41 ET on 09/01/2014.

Snapshot for Basilea Pharmaceutica (BSLN)

Open: 103.50 Day's Range: 100.00 - 104.00 Volume: 49,908
Previous Close: 103.00 52wk Range: 67.30 - 129.80 1-Yr Rtn: +52.92%

Stock Chart for BSLN

No chart data available.
  • BSLN:SW 102.00
  • 1D
  • 1M
  • 1Y
103.00
Interactive BSLN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BSLN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SMI -
Earnings Per Share (CHF) (ttm) -3.4700
Est. EPS (CHF) (12/2014) -3.6300
Est. PEG Ratio -
Market Cap (M CHF) 1,068.77
Shares Outstanding (M) 10.48
30 Day Average Volume 60,505
Price/Book (mrq) 14.8207
Price/Sale (ttm) 25.1951
Dividend Indicated Gross Yield -%
Cash Dividend (CHF) 5.0000
Dividend Ex-Date 04/11/2013
5 Year Dividend Growth -
Next Earnings Announcement 02/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BSLN

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for BSLN

Basilea Pharmaceutica AG is a biotechnology company conducting research into the development of drugs for the treatment of infectious diseases and dermatological problems. The Company develops anti-bacterial and anti-fungal compounds which destroy infectious organisms.

Domenico ScalaVice ChairmanRonald Scott "Ron"Chief Executive Officer
Donato SpotaChief Financial OfficerIngrid Heinze-KraussChief Technology Officer
More Company Profile & Key Executives for BSLN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil